Compass Biotechnologies Looks to Double Its Own Projections as It Books Its First Revenues
(firmenpresse) - LAS VEGAS, NV -- (Marketwire) -- 10/10/12 -- Compass Biotechnologies Inc.'s (PINKSHEETS: COBI) wholly owned subsidiary 1World Direct US Inc. today announced that it has booked its first revenues. 1World Direct US Inc. is now generating revenues and the company is poised to fulfill projections for the year 2012. The company believes that with recently signing 1100 new customers through its 25 Merchants it will be able to meet the 1 Million dollars in revenue projected for the fourth quarter, which is double the amount of its own recent projections. The transactions are completed from merchants as a payment to agents and included payments from agents/distributors to the Merchant Payments can be made to any country in the world in real time at the lowest cost in the global payment industry. 1World Direct US Inc. merchants can now share in real time transactions from the merchant's data base.
"Booking our first few revenue transactions is a significant milestone for 1World Direct US Inc. This is important for the company and its shareholders. Within a few months the company has completed the necessary tasks to begin to drive business and revenues at a more aggressive pace," Tom Krucker, CEO of 1World Direct US Inc.
ABOUT: 1World Direct Inc. and Compass Biotechnologies Inc.
1World Direct US Inc., a wholly owned subsidiary of Compass Biotechnologies Inc. (PINKSHEETS: COBI), integrates and provides direct payment systems into the global community that positions the company above its direct competition. 1World Direct leverages the integration of its branded cards and expands access to its stored value cards for consumers through multiple distribution channels. 1World provides a singular competitive resource for affordable funds transfer and stored value products and services generating continued profits for its shareholders.
FORWARD LOOKING STATEMENTS
Certain statements in this release, other than statements of historical fact, may include forward-looking information that involves various risks and uncertainties. There can be no assurance that such forward-looking statements will prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and expressly qualified in their entirety by this notice. The Company assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change, other than as required pursuant to applicable securities laws.
Contact:
1World Direct Inc.
Email:
Tel: 1-866-566-8078
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 10.10.2012 - 13:35 Uhr
Sprache: Deutsch
News-ID 191221
Anzahl Zeichen: 0
contact information:
Town:
LAS VEGAS, NV
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 189 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Compass Biotechnologies Looks to Double Its Own Projections as It Books Its First Revenues"
steht unter der journalistisch-redaktionellen Verantwortung von
Compass Biotechnologies Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
